AU3489595A - Recombinant macrophage migration inhibitory factor; expression in escherichia coli and purification of recombinant protein - Google Patents

Recombinant macrophage migration inhibitory factor; expression in escherichia coli and purification of recombinant protein

Info

Publication number
AU3489595A
AU3489595A AU34895/95A AU3489595A AU3489595A AU 3489595 A AU3489595 A AU 3489595A AU 34895/95 A AU34895/95 A AU 34895/95A AU 3489595 A AU3489595 A AU 3489595A AU 3489595 A AU3489595 A AU 3489595A
Authority
AU
Australia
Prior art keywords
recombinant
purification
expression
escherichia coli
inhibitory factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU34895/95A
Inventor
Andrej Francky
Bojana Mozetic Francky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU3489595A publication Critical patent/AU3489595A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU34895/95A 1994-09-19 1995-09-18 Recombinant macrophage migration inhibitory factor; expression in escherichia coli and purification of recombinant protein Abandoned AU3489595A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SI9400363 1994-09-19
SI9400363A SI9400363A (en) 1994-09-19 1994-09-19 Human macrophage migration inhibitory factor of nonlymphoid origin, expression of mif in e. coli and purification of recombinant protein
PCT/SI1995/000022 WO1996009389A2 (en) 1994-09-19 1995-09-18 Recombinant macrophage migration inhibitory factor; expression in escherichia coli and purification of recombinant protein

Publications (1)

Publication Number Publication Date
AU3489595A true AU3489595A (en) 1996-04-09

Family

ID=20431460

Family Applications (1)

Application Number Title Priority Date Filing Date
AU34895/95A Abandoned AU3489595A (en) 1994-09-19 1995-09-18 Recombinant macrophage migration inhibitory factor; expression in escherichia coli and purification of recombinant protein

Country Status (3)

Country Link
AU (1) AU3489595A (en)
SI (1) SI9400363A (en)
WO (1) WO1996009389A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6268151B1 (en) 2000-01-20 2001-07-31 Isis Pharmaceuticals, Inc. Antisense modulation of macrophage migration inhibitory factor expression
UY27304A1 (en) 2001-05-24 2002-12-31 Avanir Pharmaceuticals INHIBITORS OF THE INHIBITOR FACTOR OF MIGRATION OF MACROPHAGES AND METHODS FOR IDENTIFICATION
TW200418829A (en) 2003-02-14 2004-10-01 Avanir Pharmaceutics Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
CA2600175A1 (en) 2005-03-24 2006-03-20 Avanir Pharmaceuticals Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors
JP2014530360A (en) 2011-10-07 2014-11-17 バクスター・ヘルスケヤー・ソシエテ・アノニムＢａｘｔｅｒ Ｈｅａｌｔｈｃａｒｅ ＳＡ OxMIF as a diagnostic marker

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0463037A1 (en) * 1989-03-17 1992-01-02 Genetics Institute, Inc. Human macrophage migration inhibitory factor
US5328990A (en) * 1991-04-26 1994-07-12 The United States Of America As Represented By The Department Of Health And Human Services Isolation of macrophage migration inhibition factor from ocular lens
JP4708510B2 (en) * 1993-05-17 2011-06-22 サイトカイン ファーマサイエンシズ，インコーポレーテッド Inhibition of migration inhibitory factor in the treatment of diseases related to cytokine-mediated toxicity

Also Published As

Publication number Publication date
WO1996009389A3 (en) 1996-05-23
WO1996009389A2 (en) 1996-03-28
SI9400363A (en) 1996-08-31

Similar Documents

Publication Publication Date Title
EP0799314B8 (en) PROTEIN TYROSINE KINASES (PYK2) ITS cDNA CLONING AND ITS USES
AU4840293A (en) Cloning and expression of pur protein
AU4597596A (en) Prevention of protein aggregation
AU3321595A (en) Recombinant production of biologically active peptides and proteins
AU1852695A (en) Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof
AU4808993A (en) Chemotactic, antibiotic and lipopolysaccharide-binding peptide fragments of cap37
EP0704532A3 (en) Recombinant chimeric proteins and methods of use thereof
AU4646896A (en) Capillary electrophoresis of glycosylated proteins
GB9614700D0 (en) Over-expression of proteins in E.Coli
AU6311696A (en) Recombinant protein having bacteriophage endosialidase enzymatic activity
AU6655894A (en) Phenylalanine-free protein and dna coding therefor
AU5684594A (en) Novel human amyloid protein precursor homologue and kunitz-type inhibitors
AU4013495A (en) Chemokine-like proteins and methods of use
AU6290496A (en) High-level expression and efficient recovery of ubiquitin fusion proteins from escherichia coli
AU3489595A (en) Recombinant macrophage migration inhibitory factor; expression in escherichia coli and purification of recombinant protein
AU3571095A (en) Polypeptides and their use in treatment and prophylaxis of auto-immune disease
AU2507895A (en) Protein guarantor composition and its application
AU1636492A (en) Peptides having thrombospondin-like activity and their therapeutic use
AU1435695A (en) Recombinant human thymopoietin proteins and uses therefor
AU3241895A (en) Apoptosis related protein bcl-y, and methods of use thereof
AU3681795A (en) Polypeptide agonists and antagonists of human interleukin-8
AU3451397A (en) Modified protein g and fragments thereof
AU4257599A (en) Promoter and constructions for expression of recombinant proteins in filamentousfungi
AU7091296A (en) Polypeptides and their use in treatment and prophylaxis of auto-immune disease
HU9502114D0 (en) Expression system using autolysable fusion protein and new reducing polypeptides